Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine vs Lidocaine in MIH Maxillary Molars
NCT05585112Phase 2Completed
- Sponsor
- Tishreen University
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of articaine in Molar incisor hypomineralization (MIH) (2 arms), sponsored by Tishreen University. Primary endpoints: Injection Pain assessed by FLACC scale, Injection Pain assessed by Wong-Baker faces pain rating scale and 2 more. Started Oct 2022; status: completed.
02
Drugs
articaine
03
Conditions
Molar incisor hypomineralization (MIH)
Beyond the preview
Go deeper on NCT05585112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585112.